Acer therapeutics reports third quarter results

Acer therapeutics reports third quarter 2019 financial results and provides corporate update.q3 loss per share $0.52.q3 earnings per share estimate $-0.57 -- refinitiv ibes data.acer therapeutics - completed edsivo type a meeting following receipt of complete response letter, evaluating plans to appeal decision.ended q3 with $16.1 million in cash and cash equivalents.acer therapeutics - believes cash position to be sufficient to fund current operating, capital requirements through 2020-end.
ACER Ratings Summary
ACER Quant Ranking